Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
96.50    0.00 (0.00%)
Bid:
94.00
Ask:
99.00
Spread: 5.00 (5.319%)
Market Cap: £57.45m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Transaction in Own Shares

16 Apr 2019 07:00

Crystal Amber Fund Limited - Transaction in Own Shares

Crystal Amber Fund Limited - Transaction in Own Shares

PR Newswire

London, April 15

 16 April 2019

Crystal Amber Fund Limited

(the “Company”)

Transaction in Own Shares

The Board of Crystal Amber Fund Limited announces that, in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 23 November 2018, on Monday 15 April 2019 the Company purchased 65,000 of its own ordinary shares of 1p each (“Ordinary Shares”) at a price of 200p per share. These shares will be held as treasury shares.

Following this transaction, the total number of Ordinary Shares held as treasury shares by the Company is 2,952,782. The total number of Ordinary Shares in issue (excluding shares held as treasury shares) is 96,421,980.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the individual purchases made by Winterflood Securities on behalf of the Company as part of the buyback programme.

For further enquiries please contact: Crystal Amber Fund Limited Chris Waldron (Chairman) Tel: 01481 742 742 Allenby Capital Limited - Nominated Adviser David Worlidge /Liz Kirchner Tel: 020 7167 6431 Winterflood Securities - Broker Joe Winkley/Neil Langford Tel: 020 3100 0160 Crystal Amber Advisers (UK) LLP – Investment Adviser Richard Bernstein Tel: 020 7478 9080

Schedule of Purchases

Shares purchased: Crystal Amber Fund Limited (ISIN CODE: GG00B1Z2SL48)

Date of purchases: 15 April 2019

Investment firm: Winterflood Securities

Aggregate information:

VenueVolume-weighted average price, penceAggregated volume
London Stock Exchange200p65,000

Individual transaction:

Number of shares purchasedTransaction price (pence per share)Time of transactionTrading venue
65,000200p15:15London Stock Exchange
Date   Source Headline
20th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Aug 20244:01 pmRNSHolding(s) in Company
16th Aug 20249:45 amRNSDirector/PDMR Shareholding
16th Aug 20249:43 amRNSTransaction in Own Shares and Total Voting Rights
15th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Aug 20247:00 amRNSExtension to Share Buyback Programme
31st Jul 20245:00 pmRNSTotal Voting Rights
31st Jul 202411:50 amRNSInvestee company update: Morphic Medical Inc.
31st Jul 202411:07 amRNSMonthly Net Asset Value
26th Jul 20244:06 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Jul 20246:04 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Jul 20245:42 pmRNSTransaction in Own Shares and Total Voting Rights
28th Jun 20245:15 pmRNSTotal Voting Rights
21st Jun 20245:00 pmRNSTransaction in Own Shares and Total Voting Rights
19th Jun 202410:07 amRNSMonthly Net Asset Value
18th Jun 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Jun 20244:49 pmRNSTransaction in Own Shares and Total Voting Rights
6th Jun 20245:15 pmRNSTransaction in Own Shares and Total Voting Rights
5th Jun 20245:43 pmRNSTransaction in Own Shares and Total Voting Rights
4th Jun 202412:11 pmRNSHolding(s) in Company
4th Jun 202412:11 pmRNSHolding(s) in Company
4th Jun 20247:00 amRNSMorphic Medical – FDA approval of study amendments
3rd Jun 20245:33 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Jun 20247:00 amRNSTotal Voting Rights
31st May 20245:39 pmRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
23rd May 20241:21 pmRNSMonthly Net Asset Value
23rd May 20247:00 amRNSExtension to Share Buyback Programme
22nd May 20247:00 amRNSTransaction in Own Shares
17th May 20245:49 pmRNSTransaction in Own Shares
3rd May 20246:22 pmRNSHolding(s) in Company
2nd May 202412:37 pmRNSHolding(s) in Company
1st May 20245:22 pmRNSTransaction in Own Shares
30th Apr 20245:37 pmRNSTotal Voting Rights
29th Apr 20243:26 pmRNSHolding(s) in Company
26th Apr 20245:27 pmRNSTransaction in Own Shares
25th Apr 20247:00 amRNSHolding(s) in Company
24th Apr 20244:00 pmRNSMonthly Net Asset Value
24th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20246:22 pmRNSTransaction in Own Shares
10th Apr 20249:34 amRNSTransaction in Own Shares
3rd Apr 20244:44 pmRNSMonthly Net Asset Value
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20241:30 pmRNSExtension to Share Buyback Programme
28th Mar 20246:01 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSHalf-year Report
27th Mar 20246:27 pmRNSTransaction in Own Shares
22nd Mar 20245:09 pmRNSTransaction in Own Shares
18th Mar 20245:29 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.